ATE230760T1 - Für staphylococcus aureus spezifischer antikörper und seine verwendung - Google Patents
Für staphylococcus aureus spezifischer antikörper und seine verwendungInfo
- Publication number
- ATE230760T1 ATE230760T1 AT97915542T AT97915542T ATE230760T1 AT E230760 T1 ATE230760 T1 AT E230760T1 AT 97915542 T AT97915542 T AT 97915542T AT 97915542 T AT97915542 T AT 97915542T AT E230760 T1 ATE230760 T1 AT E230760T1
- Authority
- AT
- Austria
- Prior art keywords
- staphylococcus aureus
- antibody specific
- strains
- antibody
- immunoglobulins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9603761A FR2746398B1 (fr) | 1996-03-21 | 1996-03-21 | Anticorps specifique de staphylococcus aureaus, et utilisations |
PCT/FR1997/000510 WO1997034931A1 (fr) | 1996-03-21 | 1997-03-21 | Anticorps specifique de staphylococcus aureus et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE230760T1 true ATE230760T1 (de) | 2003-01-15 |
Family
ID=9490562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97915542T ATE230760T1 (de) | 1996-03-21 | 1997-03-21 | Für staphylococcus aureus spezifischer antikörper und seine verwendung |
Country Status (10)
Country | Link |
---|---|
US (1) | US6340571B1 (de) |
EP (1) | EP0827512B1 (de) |
JP (1) | JP4213213B2 (de) |
AT (1) | ATE230760T1 (de) |
CA (1) | CA2221893C (de) |
DE (1) | DE69718261T2 (de) |
ES (1) | ES2188927T3 (de) |
FR (1) | FR2746398B1 (de) |
PT (1) | PT827512E (de) |
WO (1) | WO1997034931A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503015A (ja) * | 1999-05-03 | 2003-01-28 | メダレツクス・インコーポレーテツド | スタフィロコッカス・アウレウスに対するヒト抗体 |
WO2001055218A1 (en) * | 2000-01-31 | 2001-08-02 | The Procter & Gamble Company | Antibodies to the staphylococcal multidrug resistance (smr) protein |
EP1695086B1 (de) * | 2003-12-09 | 2009-02-18 | BioMerieux, Inc. | Verfahren zum nachweis bakterieller krankheitserreger |
WO2005068647A2 (en) * | 2003-12-09 | 2005-07-28 | Biomerieux, Inc. | Methods for detecting bacterial pathogens |
US20100047252A1 (en) * | 2006-11-22 | 2010-02-25 | 3M Innovative Properties Company | Antibody with protein a selectivity |
US7488807B2 (en) * | 2006-11-22 | 2009-02-10 | 3M Innovative Properties Company | Antibody with protein A selectivity |
EP2240779A1 (de) * | 2008-01-18 | 2010-10-20 | 3M Innovative Properties Company | Verfahren zum nachweis eines analyts |
CA2749501C (en) | 2009-02-13 | 2017-01-10 | Immunomedics, Inc. | Immunoconjugates with an intracellularly-cleavable linkage |
US9567379B2 (en) | 2009-04-03 | 2017-02-14 | The University Of Chicago | Compositions and methods related to protein A (SpA) variants |
JP5882892B2 (ja) * | 2009-05-18 | 2016-03-09 | ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクJulius Maximilians−Universitaet Wuerzburg | 黄色ブドウ球菌エピトープIsaAまたはIsaBに対する抗体またはそれらのフラグメント |
WO2011034660A1 (en) | 2009-09-16 | 2011-03-24 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
CA2782194C (en) | 2009-12-02 | 2018-01-16 | Immunomedics, Inc. | Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer |
JP6002128B2 (ja) | 2010-07-02 | 2016-10-05 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | プロテインA(SpA)変種に関連する組成物および方法 |
AU2012250924B2 (en) | 2011-05-02 | 2017-05-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
US9315567B2 (en) | 2012-08-14 | 2016-04-19 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
DK2900277T3 (da) | 2012-12-13 | 2022-04-04 | Immunomedics Inc | Doser af immunokonjugater af antistoffer og sn-38 til forbedret effektivitet og reduceret toksicitet |
CN106132436B (zh) | 2014-02-21 | 2021-06-15 | Ibc药品公司 | 通过诱导对trop-2表达细胞的免疫应答的疾病疗法 |
EP3110445A4 (de) | 2014-02-25 | 2017-09-27 | Immunomedics, Inc. | Humanisierter rfb4-anti-cd22-antikörper |
US9580495B2 (en) | 2014-06-24 | 2017-02-28 | Immunomedics, Inc. | Anti-histone therapy for vascular necrosis in severe glomerulonephritis |
SI3204018T1 (sl) | 2014-10-07 | 2021-11-30 | Immunomedics, Inc. | Neoadjuvantna uporaba konjugatov protitelo-zdravilo |
WO2016172427A1 (en) | 2015-04-22 | 2016-10-27 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells |
EP4257134A3 (de) | 2015-06-25 | 2024-01-24 | Immunomedics, Inc. | Kombination von anti-hla-dr- oder anti-trop-2-antikörpern mit mikrotubuli-inhibitoren, parp-inhibitoren, bruton-kinase-inhibitoren oder phosphoinositol-3-kinase-inhibitoren zur signifikanten verbesserung des therapeutischen ergebnisses bei krebs |
EP3316885B1 (de) | 2015-07-01 | 2021-06-23 | Immunomedics, Inc. | Antikörper-sn-38-immunkonjugate mit einem cl2a-linker |
WO2022239720A1 (ja) | 2021-05-10 | 2022-11-17 | 公益財団法人川崎市産業振興財団 | 抗原への結合親和性を低減させた抗体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1231067A (en) * | 1983-08-16 | 1988-01-05 | Bioclones (Proprietary) Limited | Monoclonal antibody to peroxidase and hybridoma producing it |
FR2625321B1 (fr) * | 1987-12-24 | 1992-10-02 | Pasteur Institut | Reactif pour le diagnostic de staphylococcus aureus par agglutination |
US5242824A (en) * | 1988-12-22 | 1993-09-07 | Oncogen | Monoclonal antibody to human carcinomas |
US5069896A (en) * | 1989-06-01 | 1991-12-03 | The Gillette Company | Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing |
FR2679923B1 (fr) * | 1991-08-02 | 1993-10-22 | Bio Merieux | Reactif d'identification des bacteries de l'espece staphyloccocus aureus. |
-
1996
- 1996-03-21 FR FR9603761A patent/FR2746398B1/fr not_active Expired - Fee Related
-
1997
- 1997-03-21 US US08/952,052 patent/US6340571B1/en not_active Expired - Lifetime
- 1997-03-21 CA CA2221893A patent/CA2221893C/fr not_active Expired - Lifetime
- 1997-03-21 AT AT97915542T patent/ATE230760T1/de active
- 1997-03-21 DE DE69718261T patent/DE69718261T2/de not_active Expired - Lifetime
- 1997-03-21 JP JP53321297A patent/JP4213213B2/ja not_active Expired - Lifetime
- 1997-03-21 ES ES97915542T patent/ES2188927T3/es not_active Expired - Lifetime
- 1997-03-21 PT PT97915542T patent/PT827512E/pt unknown
- 1997-03-21 WO PCT/FR1997/000510 patent/WO1997034931A1/fr active IP Right Grant
- 1997-03-21 EP EP97915542A patent/EP0827512B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69718261D1 (de) | 2003-02-13 |
FR2746398A1 (fr) | 1997-09-26 |
EP0827512A1 (de) | 1998-03-11 |
CA2221893A1 (fr) | 1997-09-25 |
PT827512E (pt) | 2003-04-30 |
DE69718261T2 (de) | 2003-09-04 |
WO1997034931A1 (fr) | 1997-09-25 |
ES2188927T3 (es) | 2003-07-01 |
EP0827512B1 (de) | 2003-01-08 |
US6340571B1 (en) | 2002-01-22 |
FR2746398B1 (fr) | 1998-04-30 |
CA2221893C (fr) | 2011-05-03 |
JP4213213B2 (ja) | 2009-01-21 |
JPH11506026A (ja) | 1999-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE230760T1 (de) | Für staphylococcus aureus spezifischer antikörper und seine verwendung | |
ATE225670T1 (de) | Antagonistische anti-avb3 integrin antikörper | |
ATE386116T1 (de) | Bindungsdomänen des serrate-proteins | |
EP1423701A4 (de) | Kreuzreaktive monoklonale und polyklonale antikörper, die oberflächenprotein aus koagulasenegativen staphylococci und staphylococcus aureus erkennen | |
FI956112A0 (fi) | Monoklonaalinen anti- V-integriinivasta-aine | |
DE69128273D1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
NZ334226A (en) | Humanized immunoglobulin reactive with alpha 4 beta 7 integrin | |
PT941121E (pt) | Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais | |
DE3486146D1 (de) | Monoklonale antikoerper gegen endotoxine von gramnegativen bakterien. | |
ZA946767B (en) | Monocional antibodies having property of causing apoptosis. | |
ATE310088T1 (de) | Behandlung und nachweis von staphylokokkeninfektionen | |
DK407987D0 (da) | Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer | |
EP1227159A4 (de) | Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit | |
NO972522D0 (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
EP0554458A4 (en) | Immunoassay, monoclonal antibody and hybridoma | |
BR9702101A (pt) | Hibridoma e anticorpo monoclonal | |
DE3852914D1 (de) | Monoklonale Antikörper und Diagnoseverfahren für Phytophthora-Infektionen. | |
EP0640621A3 (de) | Monoklonaler Antikörper gegen Thrombin. | |
DE69020315D1 (de) | Monoklonaler antikörper gegen c-reaktives protein. | |
ATE263784T1 (de) | Anti-megakaryozyten monoklonaler antikörper 97a6 | |
BR9305525A (pt) | Teste de anticorpos para amilina | |
EP0450573A3 (de) | Antikörper für die Behandlung und die Diagnose von Pseudomonas aeruginosa Infektionen | |
ATE289070T1 (de) | Nachweisverfahren für microthrix parvicella | |
HUP0003029A2 (hu) | Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk | |
DE69231058D1 (de) | Hochaffine humanisierte monoklonale antikoerper |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0827512 Country of ref document: EP |